News
GENE
0.7650
+3.99%
0.0299
President Trump On Sunday Posted Video On Potential Benefits Of Hemp-Derived CBG
Benzinga · 09/29 08:33
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
Benzinga · 06/10 18:33
Watching Cannabis Stocks; Marijuana Moment Reports 'Trump White House Invites Proposal On Federal Marijuana Legalization, Activist Says'
Benzinga · 03/05 17:38
Weekly Report: what happened at GENE last week (1223-1227)?
Weekly Report · 12/30/2024 10:49
Weekly Report: what happened at GENE last week (1216-1220)?
Weekly Report · 12/23/2024 10:55
Weekly Report: what happened at GENE last week (1209-1213)?
Weekly Report · 12/16/2024 10:56
Genetic Technologies Faces Nasdaq Delisting Amid Financial Struggles
TipRanks · 12/12/2024 13:27
Weekly Report: what happened at GENE last week (1202-1206)?
Weekly Report · 12/09/2024 10:55
More
Webull provides a variety of real-time GENE stock news. You can receive the latest news about Genetic Technologies through multiple platforms. This information may help you make smarter investment decisions.
About GENE
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company's segments include EasyDNA and AffinityDNA. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses.